New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
08:51 EDTECYTEndocyte price target raised to $44 from $24 at Credit Suisse
Credit Suisse raised Enocyte's price target to $44 from $24 following CHMP's recommendation for approval of vintafolide and etarfolatide for platinum resistant ovarian cancer. Shares are Outperform rated.
News For ECYT From The Last 14 Days
Check below for free stories on ECYT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
18:35 EDTECYTOn The Fly: After Hours Movers
Subscribe for More Information
16:29 EDTECYTEndocyte reports Q2 EPS 52c, may not compare to consensus 14c
Reports Q2 revenue $49.2M, may not compare to consensus $22.09M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use